David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.75% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Financials | 7.7% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Sensata Technologies
ST
$6.11B
| $9.97M | 0.02% |
344,625
+180,094
| +109% | +$7.78M |
|
952
Akebia Therapeutics
AKBA
$250M
| $9.95M | 0.02% |
1,311,965
+524,334
| +67% | +$4.08M |
|
953
CALL
W.W. Grainger
GWW
$62.3B
| $9.94M | 0.02% |
40,000
-66,600
| -62% | -$19.7M |
|
|
LGF.B
954
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $9.91M | 0.02% |
1,776,252
-350,531
| -16% | -$2.93M |
|
|
APLS
955
DELISTED
Apellis Pharmaceuticals
APLS
| $9.9M | 0.02% |
369,733
+221,326
| +149% | +$7.86M |
|
956
CALL
McCormick & Company Non-Voting
MKC
$15.1B
| $9.9M | 0.02% |
140,200
+78,200
| +126% | +$6.07M |
|
957
Haemonetics
HAE
$4.93B
| $9.89M | 0.02% |
99,285
-3,089
| -3% | -$335K |
|
|
VAR
958
DELISTED
Varian Medical Systems, Inc.
VAR
| $9.87M | 0.02% |
96,160
-161,598
| -63% | -$21.3M |
|
959
Littelfuse
LFUS
$10.2B
| $9.82M | 0.02% |
73,621
+27,136
| +58% | +$4.54M |
|
960
PUT
General Dynamics
GD
$104B
| $9.79M | 0.02% |
74,000
-31,600
| -30% | -$5.25M |
|
|
NBIS
961
Nebius Group N.V.
NBIS
$57.3B
| $9.74M | 0.02% |
286,078
+84,544
| +42% | +$3.49M |
|
|
TWNK
962
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $9.69M | 0.02% |
909,062
-909,264
| -50% | -$11.5M |
|
|
KSU
963
DELISTED
Kansas City Southern
KSU
| $9.68M | 0.02% |
76,125
+7,261
| +11% | +$1.11M |
|
964
Selective Insurance
SIGI
$5.52B
| $9.68M | 0.02% |
194,707
+19,197
| +11% | +$1.17M |
|
965
A.O. Smith
AOS
$8.52B
| $9.65M | 0.02% |
255,175
-51,006
| -17% | -$2.17M |
|
966
Insulet
PODD
$10.1B
| $9.64M | 0.02% |
58,161
-89,452
| -61% | -$16.3M |
|
967
PUT
Sherwin-Williams
SHW
$84.2B
| $9.6M | 0.02% |
62,700
-14,100
| -18% | -$2.54M |
|
|
BMY.RT
968
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $9.59M | 0.02% |
2,524,432
-50,356
| -2% | -$166K |
|
969
PUT
American International
AIG
$40.5B
| $9.56M | 0.01% |
394,200
+129,600
| +49% | +$5.56M |
|
970
ScottsMiracle-Gro
SMG
$3.53B
| $9.56M | 0.01% |
93,353
+82,812
| +786% | +$9.11M |
|
971
Central Garden & Pet Co Class A
CENTA
$2.4B
| $9.55M | 0.01% |
466,821
-147,155
| -24% | -$3.27M |
|
972
Abercrombie & Fitch
ANF
$4.99B
| $9.53M | 0.01% |
1,048,560
-722,165
| -41% | -$10.5M |
|
973
CALL
DuPont de Nemours
DD
$18.5B
| $9.53M | 0.01% |
222,668
+30,297
| +16% | +$1.85M |
|
|
SYNH
974
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $9.52M | 0.01% |
241,581
-9,162
| -4% | -$536K |
|
975
Alcoa
AA
$13B
| $9.51M | 0.01% |
1,544,273
-962,207
| -38% | -$13.2M |
|
Similar funds
David Shaw's Q1 2020 Portfolio in Review
As of Q1 2020, David Shaw held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- David Shaw's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- David Shaw added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- David Shaw's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- David Shaw fully exited PG&E in Q1 2020, selling an estimated $79M.
- David Shaw's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- David Shaw opened 538 new positions and closed 626 in Q1 2020.
- David Shaw's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.